BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

15 related articles for article (PubMed ID: 38771994)

  • 1. Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022.
    Xiao H; Vaidya R; Hershman DL; Unger JM
    J Clin Oncol; 2024 Jun; 42(16):1953-1960. PubMed ID: 38537158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group.
    Uldrick TS; Ison G; Rudek MA; Noy A; Schwartz K; Bruinooge S; Schenkel C; Miller B; Dunleavy K; Wang J; Zeldis J; Little RF
    J Clin Oncol; 2017 Nov; 35(33):3774-3780. PubMed ID: 28968173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.
    Garcia S; Bisen A; Yan J; Xie XJ; Ramalingam S; Schiller JH; Johnson DH; Gerber DE
    J Thorac Oncol; 2017 Oct; 12(10):1489-1495. PubMed ID: 28802905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.
    Kim ES; Bruinooge SS; Roberts S; Ison G; Lin NU; Gore L; Uldrick TS; Lichtman SM; Roach N; Beaver JA; Sridhara R; Hesketh PJ; Denicoff AM; Garrett-Mayer E; Rubin E; Multani P; Prowell TM; Schenkel C; Kozak M; Allen J; Sigal E; Schilsky RL
    J Clin Oncol; 2017 Nov; 35(33):3737-3744. PubMed ID: 28968170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning enabled subgroup analysis with real-world data to inform clinical trial eligibility criteria design.
    Xu J; Zhang H; Zhang H; Bian J; Wang F
    Sci Rep; 2023 Jan; 13(1):613. PubMed ID: 36635438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the robustness of an AI pathfinder application on eligibility criteria in multiple myeloma trials using real-world data and historical trials.
    Jreich R; Zhang H; Meng Z; Wang F
    J Comp Eff Res; 2024 Jun; ():e230164. PubMed ID: 38869838
    [No Abstract]   [Full Text] [Related]  

  • 7. A data-driven approach to optimizing clinical study eligibility criteria.
    Fang Y; Liu H; Idnay B; Ta C; Marder K; Weng C
    J Biomed Inform; 2023 Jun; 142():104375. PubMed ID: 37141977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic screening improves efficiency in clinical trial recruitment.
    Thadani SR; Weng C; Bigger JT; Ennever JF; Wajngurt D
    J Am Med Inform Assoc; 2009; 16(6):869-73. PubMed ID: 19717797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matching Patients to Accelerate Clinical Trials (MPACT): Enabling Technology for Oncology Clinical Trial Workflow.
    Do NV; Elbers DC; Fillmore NR; Ajjarapu S; Bergstrom SJ; Bihn J; Corrigan JK; Dhond R; Dipietro S; Dolgin A; Feldman TC; Goryachev SD; Huhmann LB; La J; Marcantonio PA; McGrath KM; Miller SJ; Nguyen VQ; Schneeloch GR; Sung FC; Swinnerton KN; Tarren AH; Tosi HM; Valley D; Vo AD; Yildirim C; Zheng C; Zwolinski R; Sarosy GA; Loose D; Shannon C; Brophy MT
    Stud Health Technol Inform; 2024 Jan; 310():1086-1090. PubMed ID: 38269982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Impact of Revised NCI Eligibility Criteria Guidance: Prior Malignancy Exclusion in Breast Cancer Clinical Trials.
    Perez M; Murphy CC; Pruitt SL; Rashdan S; Rahimi A; Gerber DE
    J Natl Compr Canc Netw; 2022 Jul; 20(7):792-799.e4. PubMed ID: 35830895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Have Cancer Clinical Trial Eligibility Criteria Evolved Over Time?
    Yaman A; Chakrabarti S; Sen A; Weng C
    AMIA Jt Summits Transl Sci Proc; 2016; 2016():269-78. PubMed ID: 27570681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.
    Kaur M; Frahm F; Lu Y; Ascha MS; Guadamuz JS; Dotan E; Gottesman AS; Leybovich BC; Sondhi A; Zhao Y; Meropol NJ; Royce TJ
    NEJM Evid; 2024 Apr; 3(4):EVIDoa2300236. PubMed ID: 38771994
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.